GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The BC Bud Corp (XCNQ:BCBC) » Definitions » Debt-to-EBITDA

The BC Bud (XCNQ:BCBC) Debt-to-EBITDA : -0.19 (As of Aug. 2024)


View and export this data going back to 2021. Start your Free Trial

What is The BC Bud Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

The BC Bud's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was C$0.29 Mil. The BC Bud's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was C$0.00 Mil. The BC Bud's annualized EBITDA for the quarter that ended in Aug. 2024 was C$-1.56 Mil. The BC Bud's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2024 was -0.18.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for The BC Bud's Debt-to-EBITDA or its related term are showing as below:

XCNQ:BCBC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.23   Med: -0.07   Max: -0.03
Current: -0.23

During the past 3 years, the highest Debt-to-EBITDA Ratio of The BC Bud was -0.03. The lowest was -0.23. And the median was -0.07.

XCNQ:BCBC's Debt-to-EBITDA is ranked worse than
100% of 656 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs XCNQ:BCBC: -0.23

The BC Bud Debt-to-EBITDA Historical Data

The historical data trend for The BC Bud's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The BC Bud Debt-to-EBITDA Chart

The BC Bud Annual Data
Trend Feb22 Feb23 Feb24
Debt-to-EBITDA
-0.03 -0.07 -0.19

The BC Bud Quarterly Data
Aug20 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.16 -0.11 2.17 -0.19

Competitive Comparison of The BC Bud's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, The BC Bud's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The BC Bud's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The BC Bud's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where The BC Bud's Debt-to-EBITDA falls into.



The BC Bud Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

The BC Bud's Debt-to-EBITDA for the fiscal year that ended in Feb. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.229 + 0) / -1.196
=-0.19

The BC Bud's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.288 + 0) / -1.56
=-0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Aug. 2024) EBITDA data.


The BC Bud  (XCNQ:BCBC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


The BC Bud Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of The BC Bud's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


The BC Bud Business Description

Traded in Other Exchanges
Address
West Broadway, Suite 830-999, Vancouver, BC, CAN, V5Z 1K5
The BC Bud Corp is a house of brands based in British Columbia, Canada selling products in the dried flower, concentrates, vape cartridges, and edibles categories under The BC Bud Co., Solventless Solutions. brands. As a cannabis company, it focuses on creating a brand model rather than investing in redundant and low-margin cultivation facilities. Coming with a vision to embrace a world with fewer distribution borders, prioritizing the brand experience.
Executives
Karim Mohamedani 10% Security Holder
Brayden Robert Sutton Director
Thomas Taylor Director

The BC Bud Headlines

No Headlines